Login to Your Account

Pharma: Other news to note

Thursday, January 16, 2014
Helsinn Group, of Lugano, Switzerland, said it granted exclusive distribution and licensing rights to Gruppo Angelini SpA, of Rome, for the commercialization in Austria, Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovak Republic, Georgia, Russia and the other CIS countries of its compound in development for anorexia-cachexia syndrome related to non-small-cell lung cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription